Adjuvant Hepatic Arterial Infusion Pump Chemotherapy After Resection of Colorectal Liver Metastases: Results of a Safety and Feasibility Study in The Netherlands

BACKGROUND: The 10-year overall survival with adjuvant hepatic arterial infusion pump (HAIP) chemotherapy after resection of colorectal liver metastases (CRLMs) was 61% in clinical trials from Memorial Sloan Kettering Cancer Center. A pilot study was performed to evaluate the safety and feasibility...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Ann Surg Oncol
Main Authors: Buisman, Florian E., Grünhagen, Dirk J., Homs, Marjolein Y. V., Grootscholten, Cecile, Filipe, Wills F., Kemeny, Nancy E., Cercek, Andrea, D’Angelica, Micheal I., Donswijk, Maarten L., van Doorn, Leni, Emmering, Jasper, Jarnagin, William R., Kingham, T. Peter, Klompenhouwer, Elisabeth G., Kok, Niels F. M., Kuiper, Maria C., Moelker, Adriaan, Prevoo, Warner, Versleijen, Michelle W. J., Verhoef, Cornelis, Kuhlmann, Koert F. D., Groot Koerkamp, Bas
פורמט: Artigo
שפה:Inglês
יצא לאור: Springer International Publishing 2019
נושאים:
Hepatobiliary Tumors
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6863781/
https://ncbi.nlm.nih.gov/pubmed/31641947
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-019-07973-w
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים